title: Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
abstract: Renal cell carcinoma (RCC) accounts for 2.4% of all malignancies worldwide diagnosed with 338,000 estimated new cases globally in 2012. In the last decade, the therapeutic landscape for RCC patients has changed tremendously. In this review, we will summarize the treatment options currently available for clear-cell localized, advanced and metastatic RCC (mRCC); as stated in the ESMO clinical practice guidelines, the EAU guidelines and the NCCN guidelines. Furthermore, we will discuss the recommended therapies in patients diagnosed with non-clear cell tumours.
authors.affiliation: a Department of Medical Oncology , Ghent University Hospital , Ghent , Belgium.
authors.forename: T
authors.initials: T
authors.lastname: Vermassen
authors.affiliation: a Department of Medical Oncology , Ghent University Hospital , Ghent , Belgium.
authors.forename: A
authors.initials: A
authors.lastname: De Meulenaere
authors.affiliation: a Department of Medical Oncology , Ghent University Hospital , Ghent , Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Van de Walle
authors.affiliation: a Department of Medical Oncology , Ghent University Hospital , Ghent , Belgium.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Rottey
mesh_terms: D002292:Carcinoma, Renal Cell / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D007668:Kidney / Q000473:pathology; D007680:Kidney Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D018570:Risk Assessment
keywords: Renal cell carcinoma; surgery; systemic therapy